The Resource for your Nonhuman Primate Research

We offer primate antibodies and recombinant proteins for pre-clinical NHP studies, NHP-specific reagents for in vitro assays, and have an industry wide antibody reactivity database for NHP species.

Recent Publications Using Our Reagents...


Have you tried measuring anti-drug antibodies using our reagents?

Check our Anti-rhesus IgG1/3 [1B3] clone (reacts with monkey but not human IgGs!)

(also, feel free to download the NHPRR vial sticker!)

2021 December 03

A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity

Murillo Silva, Yu Kato, Mariane B Melo, Ivy Phung, Brian L Freeman, Zhongming Li, Kangsan Roh, Jan W Van Wijnbergen, Hannah Watkins, Chiamaka A Enemuo, Brittany L Hartwell, Jason Y H Chang, Shuhao Xiao, Kristen A Rodrigues, Kimberly M Cirelli, Na Li, Sonya Haupt, Aereas Aung, Benjamin Cossette, Wuhbet Abraham, Swati Kataria, Raiza Bastidas, Jinal Bhiman, Caitlyn Linde, Nathaniel I Bloom, Bettina Groschel, Erik Georgeson, Nicole Phelps, Ayush Thomas, Julia Bals, Diane G Carnathan, Daniel Lingwood, Dennis R Burton, Galit Alter, Timothy P Padera, Angela M Belcher, William R Schief, Guido Silvestri, Ruth M Ruprecht, Shane Crotty, Darrell J Irvine

Sci Immunol

Anti-CD38 [OKT10]-PE

2021 November 24

SARS-CoV-2 Infection of Rhesus Macaques Treated Early with Human COVID-19 Convalescent Plasma

Jesse D Deere, Timothy D Carroll, Joseph Dutra, Linda Fritts, Rebecca Lee Sammak, JoAnn L Yee, Katherine J Olstad, J Rachel Reader, Amy Kistler, Jack Kamm, Clara Di Germanio, Yashavanth Shaan Lakshmanappa, Sonny R Elizaldi, Jamin W Roh, Graham Simmons, Jennifer Watanabe, Rachel E Pollard, Jodie Usachenko, Ramya Immareddy, Brian A Schmidt, Shelby L O'Connor, Joseph DeRisi, Michael P Busch, Smita S Iyer, Koen K A Van Rompay, Dennis J Hartigan-O'Connor, Christopher J Miller

Microbiol Spectr

Anti-SARS-CoV Spike [CR3022]

2021 November 22

Robust IgM responses following intravenous vaccination with Bacille Calmette–Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques

Edward B. Irvine, Anthony O’Neil, Patricia A. Darrah, Sally Shin, Alok Choudhary, Wenjun Li, William Honnen, Smriti Mehra, Deepak Kaushal, Hannah Priyadarshini Gideon, JoAnne L. Flynn, Mario Roederer, Robert A. Seder, Abraham Pinter, Sarah Fortune & Galit Alter

Nature Immunology

Anti-rhesus IgA [9B9] Anti-rhesus IgG1 [ena]

2021 November 05

Diphtheria Toxin Based Bivalent Anti-cMPL Immunotoxin Effectively Depletes Human Hematopoietic Stem and Progenitor Cells

Daisuke Araki, Diogo M. Magnani, Zhirui Wang, Richard H. Smith, Andre Larochelle

Blood (2021) 138 (Supplement 1): 3808

Legacy Product Anti-CD110 [CD110IT]-Diphtheria Toxin

News & Updates:

2021 Sep 07

Anti-IFNAR therapeutic antibody now available

The rhesus recombinant anti-Interferon alpha receptor (IFNAR) 1 'Anti-IFNAR [Ani]' is now available for distribution. This antibody binds to the receptor blocking the activity of type I interferons.


2021 Feb 15

How to Cite Our Reagents Using RRIDs

We are now using Research Resource Identifiers (RRIDs) on our entire catalog to facilitate proper antibody identification. The idea behind the use of resource identifiers is simple: citation of our antibodies (using unique RRIDs) will automatically associate specific reagents with your publication.

2021 Apr 02

Stabilized Spike Glycoproteins for COVID Research

We have produced stabilized Spike proteins for NIAID, now offered through BEI. Please check the details on the constructs and order them directly from (cat. NR-52724, NR-53937)


2021 Feb 06

New Resources for Neotropical Primates (NT-NHP)

Dear NHPRR Community, we are pleased to announce our new efforts to provide reagents specifically tailored for neotropical primates (NT-NHP), especially marmosets, squirrel monkeys, and owl monkeys. Please reach us if you are interested!

Contribute to the Resource

Help Us By:

Sharing Your Data: Our community-based reactivity database is built by users like you. Share your results!

Requesting a Reagent: We develop NHP-specific antibodies based on investigator-initiated requests, including: recombinant proteins for cell depletion, receptor activation, cytokine neutralization, co-stimulatory blockade, immunosuppression.

Licensing Our Reagents: Interested in using our antibodies on your assays? Reach us!

Sharing Your Publication: If you’ve recently published a study using an NHPRR reagent, add it to the publication database.